| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |